Ishita Drugs & Industries Share Price

BSE
ISHITADR •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Ishita Drugs & Industries
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
27.45% Fall from 52W High
-14.6
Dividend yield 1yr %
0

Ishita Drugs & Industries shareholding Pattern

Promoter
49.8%
Public
50.1%
Promoter
49.8%
Public
50.2%
Promoter
49.8%
Public
50.2%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%
Promoter
49.4%
Public
50.6%

Ishita Drugs & Industries Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
16
5Day EMA
76.60
10Day EMA
77.00
12Day EMA
77.10
20Day EMA
77.80
26Day EMA
78.40
50Day EMA
80.40
100Day EMA
81.10
200Day EMA
79.20
5Day SMA
77.00
10Day SMA
76.90
20Day SMA
76.70
30Day SMA
78.40
50Day SMA
82.30
100Day SMA
82.70
150Day SMA
81.90
200Day SMA
78.80
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
605 Rs
622 Rs
Week Rs
432 Rs
528 Rs
Month Rs
562 Rs
705 Rs
Resistance & Support
76.35
Pivot
Resistance
First Resistance
78.55
Second Resistance
81.10
Third Resistance
83.30
Support
First Support
73.80
Second support
71.60
Third Support
69.05
Relative Strength Index
46.74
Money Flow Index
31.88
MACD
-1.28
MACD Signal
-1.47
Average True Range
6.16
Average Directional Index
11.76
Rate of Change (21)
-5.64
Rate of Change (125)
-5.33

Ishita Drugs & Industries Company background

Founded in: 1992
Managing director: Jagdish Agrawal
Ishita Drugs Industries Limited was incorporated in Feb.92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a stateofart manufacturing facility, in terms of reaction capabilities, quality control and environmental safety. The plant has been designed and constructed to meet GMP norms.The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana).Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.95. It established an inhouse RD laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.95.The Company in 2009 undertook a small expansion cumdebottlenecking project it upgraded many existing equipments.
Read More

Ishita Drugs & Industries FAQs

You can easily buy Ishita Drugs & Industries shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Ishita Drugs & Industries stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -